Adenoviral vectors targeted to CD40 enhance the efficacy of dendritic cell-based vaccination against human papillomavirus 16-induced tumor cells in a murine model
B. W. Tillman, T. L. Hayes, T. D. DeGruijl, J. T. Douglas, D. T. Curiel
Dive into the research topics of 'Adenoviral vectors targeted to CD40 enhance the efficacy of dendritic cell-based vaccination against human papillomavirus 16-induced tumor cells in a murine model'. Together they form a unique fingerprint.